The FDA Wants Physicians on Its Advisory Committees. Here Is How to Apply.
The agency has opened a nationwide call for voting members and consumer representatives across its advisory panels. Nominations for first consideration are due in November, and self-nominations count.
Physicians who want a say in how drugs and devices are evaluated now have an open invitation. On Sept. 30 the agency announced a nationwide recruitment effort for its advisory committees, the independent panels that advise it on drugs, vaccines, biologics, medical devices and other regulated products.
What the FDA is looking for
The agency is publishing two Federal Register notices. One seeks scientific, technical and professional voting members for all committees with current or anticipated vacancies. The other seeks consumer representatives. The FDA said the vacancies span multiple fields, from oncology and cardiovascular medicine to neurology, genetics and medical devices.
Nominees for the scientific and technical voting seats must show subject-matter expertise relevant to one or more committees, the ability to interpret complex scientific and technical information, an understanding of the public health significance of the issues before the committee, and the capacity to give objective, independent advice. Consumer representatives should have an affiliation with or active role in consumer or community organizations and the ability to analyze technical data and weigh benefits and risks from a public perspective.
Self-nominations are accepted. The physician who has spent years thinking about a class of drugs does not need to wait to be asked.
Deadlines and terms
Nominations are accepted on a continuing basis, but timing matters. To receive first consideration for current and near-term vacancies, consumer representative nominations should be submitted by Nov. 15, 2026, and nominations for scientific, technical, professional and other voting positions by Nov. 30, 2026. Later nominations will be considered as other vacancies arise. Members are invited to serve terms of up to four years, and applications begin through the FDA's advisory committee membership nomination portal.
Acting FDA Commissioner Kyle Diamantas said the agency is inviting "clinicians, researchers, and community voices who can bring the latest science, real-world experience, and fresh perspectives" to its deliberations.
Is it worth your time?
That depends on what you want from the rest of your career. Advisory committee work is public service, and it asks for careful reading of dense evidence and a willingness to vote in public on hard questions. For physicians drawn to regulatory science, to evidence appraisal, or to shaping how new therapies reach patients, it is one of the few roles where a practicing clinician's judgment feeds directly into a national decision.
Before applying, it is worth talking with your department chair or employer about time away from clinical work, and reading the Federal Register notice for the committee that matches your expertise closely enough to explain, in a sentence or two, what you would bring to it. A clear statement of expertise is what the FDA's criteria ask nominees to demonstrate.
Few physicians will ever serve on one of these panels, but the only way onto one is through a nomination. The November deadlines are a reasonable prompt to decide whether to submit yours.
Dr. Lindqvist is a psychiatrist focused on clinician wellbeing, moral injury, and sustainable careers in medicine.
This article is for professional education and does not replace clinical judgment. Treatment decisions should be based on the individual patient and current guidelines.
